🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted action to tackle cost of living pressures" in the forthcoming financial statement.

In comments to media outlets, she emphasized that curbing price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven developed nations this year and the following year.

Potential Energy Cost Interventions

Reports indicate the government could take action to reduce energy bills, for instance by cutting the current 5% rate of VAT applied on energy supplies.

An additional approach is to reduce some of the regulatory levies currently added to household expenses.

Fiscal Limitations and Expert Expectations

The government will obtain the latest draft from the official forecaster, the OBR, on Monday, which will show how much space there is for these measures.

The consensus from the majority of experts is that Reeves will have to announce tax rises or spending cuts in order to fulfill her self-imposed fiscal targets.

Previously on Thursday, analysis indicated there was a £22 billion deficit for the Treasury chief to address, which is at the more modest range of forecasts.

"It is a shared task between the central bank and the administration to further reduce some of the sources of price increases," Reeves informed reporters in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While a great deal of the attention has been on likely tax increases, the Treasury chief said the most recent data from the OBR had not changed her pledge to manifesto promises not to increase rates on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing international and trade tensions for the Budget tax moves, likely to be targeted on those "wealthiest."

Global Economic Tensions

Commenting on apprehensions about the UK's trade ties with China she said: "The UK's security interests invariably come first."

Last week's declaration by China to tighten trade restrictions on critical minerals and other resources that are key for advanced tech manufacturing led US President the US President to threaten an extra 100% tariff on imports from China, raising the prospect of an all-out trade war between the two largest economies.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a international production control attempt."

Questioned on accepting the American proposal to join its conflict with China, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "bad for the world economy and causes additional challenges."

"I believe there are sectors where we need to confront Chinese policies, but there are also important opportunities to sell into China's economy, including financial services and other areas of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also stated she was collaborating with international partners "regarding our own critical minerals plan, so that we are reduced dependence."

NHS Medicine Pricing and Funding

The Chancellor also recognized that the price the National Health Service pays for drugs could rise as a result of ongoing discussions with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the UK, with some blaming the insufficient payments they are receiving.

Recently, the Science Minister said the cost the NHS spends on medicines would must go up to prevent businesses and drug research funding leaving the United Kingdom.

The Chancellor told media: "We have seen as a result of the payment system, that clinical trials, recent pharmaceuticals have not been offered in the UK in the way that they are in other EU nations."

"The objective is to guarantee that patients getting care from the NHS are able to receive the finest critical drugs in the world. And so we are examining all of that, and... looking to secure more capital into the UK."